These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8096722)

  • 1. The use of the dog in toxicity tests on pharmaceutical compounds.
    Parkinson C; Grasso P
    Hum Exp Toxicol; 1993 Mar; 12(2):99-109. PubMed ID: 8096722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
    Tibbitts J
    Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of minipig, dog, monkey and human drug metabolism and disposition.
    Dalgaard L
    J Pharmacol Toxicol Methods; 2015; 74():80-92. PubMed ID: 25545337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies prediction of human drug clearance based on scaling data from one or two animal species.
    Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E
    Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and toxicity testing.
    Clark B; Smith DA
    Crit Rev Toxicol; 1984; 12(4):343-85. PubMed ID: 6378530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of pharmacokinetics in drug safety evaluation.
    Singhvi SM; Keim GR; Migdalof BH
    Regul Toxicol Pharmacol; 1985 Mar; 5(1):3-17. PubMed ID: 3991931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Matrix Method Provides A Reliable Metabolite Exposure Comparison for Assessment of Metabolites in Safety Testing (MIST).
    Takahashi RH; Khojasteh C; Wright M; Hop CECA; Ma S
    Drug Metab Lett; 2017 Nov; 11(1):21-28. PubMed ID: 28699487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the pentagastrin dog model to explore the food effects on formulations in early drug development.
    Zane P; Guo Z; MacGerorge D; Vicat P; Ollier C
    Eur J Pharm Sci; 2014 Jun; 57():207-13. PubMed ID: 24090732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between pharmacokinetics and toxicokinetics.
    Welling PG
    Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug metabolites in safety testing.
    Hastings KL; El-Hage J; Jacobs A; Leighton J; Morse D; Osterberg RE
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):91-2;author reply 93-4. PubMed ID: 12831788
    [No Abstract]   [Full Text] [Related]  

  • 17. The concept of multispecies testing in industrial toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies extrapolation in safety evaluation of human medicines in The Netherlands (1990-1992): practical considerations.
    Peters-Volleberg GW; De Waal EJ; Van der Laan JW
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):248-58. PubMed ID: 7724833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of population pharmacokinetics for preclinical safety and efficacy studies.
    Porzio S
    Bioanalysis; 2013 Aug; 5(16):2053-69. PubMed ID: 23937139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.